Niranjan Kanesa-thasan - May 31, 2022 Form 5 Insider Report for Icosavax, Inc. (ICVX)

Role
Chief Medical Officer
Signature
/s/ Elizabeth Bekiroglu, Attorney-in-Fact
Stock symbol
ICVX
Transactions as of
May 31, 2022
Transactions value $
$9,619
Form type
5
Date filed
2/14/2023, 04:19 PM
Previous filing
Feb 14, 2022
Next filing
Aug 2, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ICVX Common Stock Award $9.62K +1.67K +0.7% $5.77 241K May 31, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were acquired under the Issuer's Employee Stock Purchase Plan on May 31, 2022 by the Reporting person in a transaction exempt from Section 16(b) pursuant to Rule 16b-3(c).